The Partnership for Health Advancement in Vietnam (HAIVN) is a collaboration between Harvard Medical School (HMS) and two HMS-affiliated teaching hospitals, Beth Israel Deaconess Medical Center (BIDMC), and Brigham and Women’s Hospital (BWH).
Our staff includes experts in clinical medicine, medical education, health systems, healthcare quality improvement, monitoring and evaluation, and implementation research.
HAIVN supports Vietnam’s health system through a comprehensive approach to building healthcare worker capacity. This includes:
(1) strengthening medical education through curriculum innovation and faculty development.
(2) providing training, mentoring, and coaching in HIV and strengthening systems and capacity for technical assistance in the country.
(3) supporting the Vietnam Ministry of Health to develop policies and regulations that support quality medical education and medical care such as systems of accreditation and licensing.
- HAIVN Program Jan 22, 2019 - Session 10: ARV drugs and side effects in the first class of anti-HIV drugs - Case discussion
- HCMC PAC Program Jan 23, 2019 Recency testing and info testing results HIV testing for PEP staff in OPCs
- HAIVN Program Jan 23, 2019 - Session 11: Pre-exposure prophylaxis and Standard Precautions - Case discussion
- NHTD Program Jan 23, 2019 - Skin damage due to toxicity of ART medication - Liver toxicity in HIV patients who are on ART
- HAIVN Program Jan 25, 2019 - ARV treatment failure workshop - E-men program on VL roll-out and treatment failure
- NHTD Program Jan 25, 2019 - Treatment failure - ARV medication resistance
- HAIVN Program Jan 29, 2019 - Session 12: Following up antiretroviral treatment - Session 13: Antiretroviral treatment adherence - Case discussion - Post-test - Closing training course